Everence Capital Management Inc Vanda Pharmaceuticals Inc. Transaction History

Everence Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	BUY	$6.87 - $10.96 $103,737 - $165,496	15,100 Added 138.66%	25,990 $192,000
Q2 2020 Jul 09, 2020	BUY	$9.66 - $12.02 $105,197 - $130,897	10,890 New	10,890 $128,000
Q2 2020 Jul 07, 2020	SELL	$9.66 - $12.02 $105,197 - $130,897	-10,890 Closed	0 $0
Q1 2020 Jul 09, 2020	BUY	$7.5 - $16.8 $81,675 - $182,952	10,890 New	10,890 $113,000

157

44.9M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $244M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Everence Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Everence Capital Management Inc with notifications on news.